Result of AGM

September 30, 2019

Download full announcement

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces at its annual general meeting held earlier today, the following resolutions were passed on a show of hands with the table below summarising proxy votes:

  Resolution Votes for* Votes against Votes withheld
1 To receive the audited accounts of the Company 24,481,789  22 0
2 To re-elect Julian Baines 24,481,789  22 0
3 To re-elect Christopher Mills 20,570,985  3,910,826  0
4 To re-elect Richard Evans 24,481,789  22 0
5 To re-elect Fergus Fleming 24,481,789  22 0
6 To elect Doctor Erik Lium 24,481,789  22 0
7 To elect James McCullough 24,481,789  22 0
8 To elect Barbara Murphy 24,481,811  0 0
9 To re-appoint the auditors PKF Littlejohn LLP and authorise the Directors to fix their remuneration 24,481,789  22 0
10 To authorise the directors to replace the existing authority to allot shares in the Company in connection with s551 of the Companies Act 2006 24,481,789  22 0
11 To authorise the directors to allot Relevant Securities as if s561 of the Companies Act 2006 did not apply 23,769,147  702,664   10,000

 

*Any proxy appointments, which gave discretion to the Chairman have been included in the ‘For’ votes total.


Enquiries

Renalytix AI plc www.renalytixai.com
James McCullough, CEO Via Walbrook PR
   
Stifel (Nominated Adviser & Joint Broker) Tel: 020 7710 7600

Alex Price / Jonathan Senior / Ben Maddison (Investment Banking)

 
   
N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000
Aubrey Powell / James White / George Tzimas (Corporate Finance)
Tom Salvesen / Mia Gardner (Corporate Broking)
 
   
Walbrook PR Limited Tel: 020 7933 8780
renalytix@walbrookpr.com
Paul McManus
Lianne Cawthorne
Mob: 07980 541 893
07584 391 303